Leadership Overview
Sanofi has 10 executives leading key functions including strategy, finance, and marketing.
Driven by scientific innovation, Sanofi is dedicated to improving lives through the discovery, development, and delivery of medicines and vaccines across critical therapeutic areas, working with global healthcare partners to advance sustainable solutions.
Driven by scientific innovation, Sanofi is dedicated to improving lives through the discovery, development, and delivery of medicines and vaccines across critical therapeutic areas, working with global healthcare partners to advance sustainable solutions.
Leadership Roles at Sanofi
Sophie Hurson - Chief Financial Officer, Cambodia (Vietnam) & Excom Board Member
Sophie Hurson, the Chief Financial Officer, Cambodia (Vietnam) & Excom Board Member at Sanofi, directs financial operations and strategic fiscal planning for the Cambodian and Vietnamese markets. Hurson manages all financial aspects, including budgeting, forecasting, and financial reporting, ensuring compliance with local regulations and international standards. As an Excom Board Member, Sophie Hurson contributes to high-level strategic decision-making, aligning financial strategies with the company's global objectives. This leadership role is crucial for driving financial performance and supporting Sanofi's expansion in key Southeast Asian markets. The Chief Financial Officer, Cambodia (Vietnam) & Excom Board Member ensures robust financial health, enabling the company to continue its mission of delivering innovative medicines and vaccines.
AbdulQadir Khan - Chief Financial Officer & Regional Greater Gulf Headquarters Finance Business Partner (Saudi & Gulf)
AbdulQadir Khan, the Chief Financial Officer & Regional Greater Gulf Headquarters Finance Business Partner (Saudi & Gulf) at Sanofi, leads financial strategy and operations across the Greater Gulf region. Khan oversees financial planning, analysis, and reporting, ensuring fiscal discipline and driving profitable growth in Saudi Arabia and the Gulf countries. This executive position involves acting as a key finance business partner, providing strategic financial insights to regional leadership and supporting business unit objectives. The Chief Financial Officer & Regional Greater Gulf Headquarters Finance Business Partner (Saudi & Gulf) is instrumental in managing financial risks and opportunities, contributing to Sanofi's mission of delivering essential medicines and vaccines. AbdulQadir Khan's expertise ensures robust financial management across a significant operational territory.
Saurav Mimani - Chief Financial Officer (Saudi Arabia & Gulf Countries)
Saurav Mimani, the Chief Financial Officer (Saudi Arabia & Gulf Countries) at Sanofi, manages financial operations and strategic planning for the specified regions. Mimani oversees budgeting, forecasting, and financial analysis, ensuring fiscal responsibility and supporting business growth initiatives. This role is critical for navigating the financial landscape of Saudi Arabia and the Gulf Countries, aligning local financial activities with Sanofi's global strategy. The Chief Financial Officer (Saudi Arabia & Gulf Countries) ensures compliance with financial regulations and drives efficiency in financial processes. Saurav Mimani's leadership contributes to the financial stability and operational success of Sanofi in these key markets, supporting the delivery of vital healthcare solutions.
Colleen Proctor - Chief Financial Officer (North America)
Colleen Proctor, the Chief Financial Officer (North America) at Sanofi, directs financial strategy and operations across the North American region. Proctor oversees all financial activities, including budgeting, forecasting, financial reporting, and capital allocation, ensuring robust financial health and driving profitable growth. This executive role is pivotal in supporting Sanofi's strategic objectives within one of its largest markets. The Chief Financial Officer (North America) ensures compliance with financial regulations and optimizes financial performance to support the delivery of innovative medicines and vaccines. Colleen Proctor's leadership strengthens Sanofi's financial foundation, enabling continued investment in scientific innovation and patient-focused solutions across North America.

Sudika Pillai - Chief of Staff
Sudika Pillai, the Chief of Staff at Sanofi, directs strategic initiatives and operational alignment across key departments. This role involves facilitating communication between executive leadership and various functional teams, ensuring seamless execution of corporate objectives. Pillai oversees the implementation of critical projects, driving efficiency and fostering collaboration to advance Sanofi's mission of improving lives through scientific innovation. The Chief of Staff manages cross-functional task forces, ensuring timely delivery of complex projects and supporting the overall strategic direction of the biopharmaceutical company. This leadership position is central to maintaining organizational agility and responsiveness in a dynamic global market, directly impacting the company's ability to deliver life-changing medicines and vaccines.
Amber Doss - Chief of Staff, Specialty Care
Amber Doss, the Chief of Staff, Specialty Care at Sanofi, spearheads operational strategies and program management within the Specialty Care division. Doss ensures the effective deployment of resources and drives initiatives that enhance the delivery of innovative treatments for immunology, rare diseases, and neurology. This executive role involves close collaboration with R&D, commercial, and medical affairs teams to accelerate product development and market access. The Chief of Staff, Specialty Care oversees critical operational workflows, optimizing processes to support Sanofi's commitment to patient well-being. Doss's leadership ensures that the Specialty Care unit operates with maximum efficiency, contributing significantly to the company's goal of advancing sustainable healthcare solutions across its specialized therapeutic areas.
Erin Hayes - Head of Franchise Operations & Chief of Staff (Interim)
Erin Hayes, the Head of Franchise Operations & Chief of Staff (Interim) at Sanofi, manages critical franchise operations and provides interim leadership support for strategic initiatives. Hayes oversees the operational execution of franchise-specific goals, ensuring alignment with Sanofi's broader business objectives. This dual role involves optimizing operational workflows and facilitating executive decision-making during the interim period. The Head of Franchise Operations & Chief of Staff (Interim) plays a vital part in maintaining business continuity and driving forward key projects. Erin Hayes's focus is on enhancing operational efficiency and supporting the seamless delivery of Sanofi's therapeutic solutions, reinforcing the company's commitment to scientific innovation and patient care.
KwangYong Nam - Director, Em & S Operational Quality & Chief Marketing Officer, Management
KwangYong Nam, the Director, Em & S Operational Quality & Chief Marketing Officer, Management at Sanofi, directs quality assurance within manufacturing operations and oversees marketing management functions. Nam ensures adherence to stringent quality standards across Sanofi's manufacturing processes, safeguarding product integrity and patient safety. This leadership role also encompasses strategic marketing oversight, driving brand initiatives and market positioning for key management areas. The Director, Em & S Operational Quality & Chief Marketing Officer, Management plays a critical part in maintaining operational excellence and enhancing market presence. KwangYong Nam's dual focus on quality and marketing management supports Sanofi's commitment to delivering high-caliber biopharmaceutical products and advancing healthcare solutions globally.
Penny Thomas - Chief Marketing Officer & Quality Specialist
Penny Thomas, the Chief Marketing Officer & Quality Specialist at Sanofi, leads marketing strategies and ensures specialized quality oversight for key initiatives. Thomas develops and executes comprehensive marketing plans designed to enhance Sanofi's market presence and communicate the value of its innovative medicines and vaccines. Concurrently, Penny Thomas applies expertise as a Quality Specialist, contributing to the maintenance of high operational standards and regulatory compliance. This dual focus ensures that marketing efforts are both impactful and aligned with the company's rigorous quality commitments. The Chief Marketing Officer & Quality Specialist drives brand awareness and market penetration while upholding Sanofi's dedication to scientific innovation and patient well-being.
Matthew Roehr - Deputy Director & Chief Marketing Officer, Quality External Manufacturing
Matthew Roehr, the Deputy Director & Chief Marketing Officer, Quality External Manufacturing at Sanofi, directs marketing efforts and operational quality within external manufacturing partnerships. Roehr develops and implements marketing strategies to enhance Sanofi's external manufacturing relationships and promote its capabilities. This role also involves ensuring stringent quality standards are met by external manufacturing partners, safeguarding product integrity and supply chain reliability. The Deputy Director & Chief Marketing Officer, Quality External Manufacturing plays a key part in optimizing Sanofi's external manufacturing network and market positioning. Matthew Roehr's leadership ensures that external manufacturing operations align with Sanofi's commitment to delivering high-quality medicines and vaccines.
Explore Leadership Teams in Manufacturing
Wockhardt Ltd. founded in 1999, is a global pharmaceutical and biotechnology company headquartered in Mumbai, India. The Company's businesses include the manufacture and marketing of pharmaceutical and bio-pharmaceutical formulations, active pharmaceutical ingredients, and vaccines.
Company Leadership NT
DM
NJ
PK
Biogen is a U.S.-based biotechnology company focused on discovering, developing, and commercializing therapies for serious neurological and neurodegenerative diseases. Its core portfolio includes treatments for conditions such as multiple sclerosis, spinal muscular atrophy, and other rare neurological disorders, supported by advanced research in neuroscience, biologics, and gene-based therapies.
Company Leadership
RK
KH
WC
Amgen Inc. (Nasdaq: AMGN) is a leading American multinational biotechnology company headquartered in Thousand Oaks, California. Founded in 1980 as Applied Molecular Genetics, Amgen pioneered the biotech industry and remains at the forefront of scientific innovation.
Company Leadership LF

Zydus is a global pharmaceutical company headquartered in Ahmedabad, India. Founded in 1952, the company operates manufacturing sites and research facilities across multiple states in India as well as in the United States and Brazil. Zydus specializes in developing, manufacturing, and distributing pharmaceutical products with a significant global footprint. The company maintains a strong presence in regulated markets including the United States, Europe, Latin America, and South Africa, while also serving numerous emerging markets worldwide. Zydus offers a comprehensive portfolio of pharmaceutical products and services, supported by extensive research and development capabilities.
Company Leadership SK
KT
RR